Nitrite, endothelin and E-selectin plasma levels after arginine infusion in normal and vasculopathic subjects
- PMID: 10209938
Nitrite, endothelin and E-selectin plasma levels after arginine infusion in normal and vasculopathic subjects
Abstract
Background: The authors carried out a study on the simultaneous modifications of nitrite, endothelin and E-selectin plasma levels after infusion of arginine (a precursor of nitric oxide endothelial synthesis) in normal and vasculopathic subjects.
Methods: The series consisted of 24 female subjects (mean age 58 +/- 7) of which: 12 normal controls; 12 suffering from chronic cerebral vascular disease and coronary heart diseases. Each subject, after a venous blood withdrawal, received arginine (20 g over 2 hours); withdrawals were repeated after 60 and 120 minutes. The levels of total nitrites (NO2-, colorimetric method), endothelin (ET-1, ELISA method) and E-selectin (E-s, ELISA method) were determined on each plasma sample.
Results: The levels of NO2-, specific end-products of nitric oxide, did not show significant changes after arginine infusion in the vasculopathic subjects (group B), whereas in the normal subjects (group A) a significant reduction was recorded. The ET-1 levels after arginine did not show significant differences between the two groups. The values of E-selectin presented no significant variations after arginine in the two groups. The basal values of nitrites, endothelin and E-selectin was significantly (p < 0.05) lower in group B than in group A.
Conclusions: In conclusion, this study has demonstrated that arginine infusion did not alter the nitrite, endothelin and E-selectin plasma levels within two hours in vasculopathic subjects, suggesting a probable wide abiotrophic damage of the endothelial structures. The reduction of nitrites after arginine in the normal subjects may depend of an inverse organification process due to an enhanced bio-synthesis of nitric oxide.
Similar articles
-
Nitrite, endothelin and E-selectin plasma levels after arginine infusion in normal, obese and type 2 diabetic subjects.Minerva Endocrinol. 2000 Jun;25(2):33-7. Minerva Endocrinol. 2000. PMID: 11189789
-
Protective effects of L-arginine against ischemia-reperfusion injury in non-heart beating rat liver graft.Hepatobiliary Pancreat Dis Int. 2008 Oct;7(5):481-4. Hepatobiliary Pancreat Dis Int. 2008. PMID: 18842493
-
Plasma levels of E-selectin in normolipemic and hyperlipemic arteriopathic patients after vasoactive and lipid-lowering treatment.Minerva Cardioangiol. 2000 Mar;48(3):47-52. Minerva Cardioangiol. 2000. PMID: 10838833 English, Italian.
-
Nitrite plasma levels in acute and chronic coronary heart disease.Minerva Cardioangiol. 1997 Nov;45(11):553-8. Minerva Cardioangiol. 1997. PMID: 9549288 Review.
-
L-arginine infusion decreases plasma total homocysteine concentrations through increased nitric oxide production and decreased oxidative status in Type II diabetic patients.Diabetologia. 2002 Aug;45(8):1120-7. doi: 10.1007/s00125-002-0854-1. Epub 2002 Jun 22. Diabetologia. 2002. PMID: 12189442 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical